Gallbladder actinomycosis: Is it a complication after radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma?

Gallbladder actinomycosis: Is it a complication after radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma?

Bibliographic Details
Main Authors:	Han Hyung, Choi Sae, Kim Wan, Song Tae, Choi Sang
Format:	Article
Language:	English
Published:	De Gruyter 2011-06-01
Series:	Open Medicine
Subjects:	actinomycosis gallstone hepatocellular carcinoma chemoembolization radiofrequency ablation
Online Access:	https://doi.org/10.2478/s11536-011-0006-4

Similar Items

Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud A. Dawoud, et al.
Published: (2017-12-01)

Transarterial chemoembolization with radiofrequency ablation versus hepatectomy in hepatocellular carcinoma beyond the Milan criteria: a retrospective study
by: Yuan H, et al.
Published: (2018-11-01)

Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma
by: Lei Chen, et al.
Published: (2020-06-01)

Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment
by: Ah Ran Kim, et al.
Published: (2019-03-01)

Early experience of combination therapy of transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma measuring 3–7 cm
by: Yashwant Patidar, et al.
Published: (2019-01-01)

Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study
by: Yanqiao Ren, et al.
Published: (2019-10-01)

Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation
by: Byung-Yoon Yun, et al.
Published: (2020-09-01)

A Comparison of Adverse Events Among Radiofrequency Ablation, Conventional Transarterial Chemoembolization (TACE) and Drug-Eluting Bead TACE in Treating Hepatocellular Carcinoma Patients
by: Cao G, et al.
Published: (2021-07-01)

The influence on liver function after transcatheter arterial chemoembolization combined with percutaneous radiofrequency ablation in patients with hepatocellular carcinoma
by: Jia-Xin Li, et al.
Published: (2012-09-01)

Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study
by: Liangliang Yan, et al.
Published: (2021-04-01)

Clinical efficacy of chemoembolization with simultaneous radiofrequency ablation for treatment of adrenal metastases from hepatocellular carcinoma
by: Hongjun Yuan, et al.
Published: (2018-07-01)

Comparison of transcatheter arterial chemoembolization combined with radiofrequency ablation or microwave ablation for the treatment of unresectable hepatocellular carcinoma: a systemic review and meta-analysis
by: Jiani Zhao, et al.
Published: (2020-01-01)

Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Large Hepatocellular Carcinomas
by: Tai-Yang Zuo, et al.
Published: (2017-01-01)

Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis
by: Chuang Jiang, et al.
Published: (2021-03-01)

Fusion imaging-guided radiofrequency ablation for residual hepatocellular carcinoma invisible on ultrasound after transcatheter arterial chemoembolization
by: Jiong-Hui Gu, et al.
Published: (2021-01-01)

Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study
by: Xiaoyan Ding, et al.
Published: (2020-10-01)

Transarterial Chemoembolization Combined With Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma After Curative Resection: A 10-Year Single-Center Comparative Study
by: Xin Zheng, et al.
Published: (2021-09-01)

Clinical effect of transarterial chemoembolization combined with radiofrequency ablation in treatment of rabbit VX2 liver tumors
by: LI Hao, et al.
Published: (2018-04-01)

Risk Factors, Patterns, and Long-Term Survival of Recurrence After Radiofrequency Ablation With or Without Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Jingjun Huang, et al.
Published: (2021-05-01)

Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis
by: Chih-Wen Lin, et al.
Published: (2020-04-01)

A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation
by: Shiji Fang, et al.
Published: (2021-08-01)

Transarterial Chemoembolization and Sorafenib Combined with Microwave Ablation for Advanced Primary Hepatocellular Carcinoma: A Preliminary Investigation of Safety and Efficacy
by: Ni JY, et al.
Published: (2019-11-01)

Gallbladder Perforation after Transarterial Chemoembolization in a Patient with a Huge Hepatocellular Carcinoma
by: Min Young Son, et al.
Published: (2020-07-01)

Combined ultrasound/computed tomography guidance in percutaneous radiofrequency ablation after transarterial chemoembolization for hepatocellular carcinoma in the hepatic dome
by: Kan X, et al.
Published: (2019-08-01)

Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma
by: Yun Xu, et al.
Published: (2017-01-01)

Combined versus single locoregional therapy in the treatment of unresectable hepatocellular carcinoma
by: Moustafa H.M. Othman, et al.
Published: (2014-06-01)

Diagnostic value of apparent diffusion coefficient (ADC) in evaluating hepatocellular carcinomas post trans-catheter arterial chemoembolization and radiofrequency ablation
by: Hazim I. Tantawy, et al.
Published: (2016-09-01)

Research advances in sorafenib combined with orthotopic liver transplantation, radiofrequency ablation, and transarterial chemoembolization in treatment of hepatocellular carcinoma
by: ZHANG Mingjuan
Published: (2014-08-01)

A Rare Complication Following Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Wei-Chen Lin, et al.
Published: (2015-12-01)

Radiological response in Saudi patients undergoing transarterial chemoembolization for hepatocellular carcinoma
by: Al Fuhaid Turki, et al.
Published: (2007-01-01)

Comparative Analysis of Radiofrequency Ablation and Microwave Ablation for Critically Located Hepatocellular Carcinomas Smaller than 5 cm
by: Ravindran Ramalingam, et al.
Published: (2021-01-01)

The efficacy of transarterial chemoembolization combined with microwave ablation for unresectable hepatocellular carcinoma: a systematic review and meta-analysis
by: Lei Wang, et al.
Published: (2019-01-01)

Liver Abscess Formation after Radiofrequency Ablation of Hepatocellular Carcinoma
by: Juwon Kim, et al.
Published: (2017-10-01)

Curative effect of transcatheter arterial chemoembolization combined with radiofrequency ablation in treating hepatic cell carcinoma and the effect on serum markers
by: Fu-Qiang Jiang,, et al.
Published: (2016-04-01)

Transarterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin-Loaded Tandem Drug-Eluting Embolics
by: Boris Guiu, et al.
Published: (2019-07-01)

Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma
by: Tae Wook Kang, et al.
Published: (2017-03-01)

Comparison of Microwave Ablation and Transarterial Chemoembolization for Single-Nodule Hepatocellular Carcinoma Smaller Than 5cm: A Propensity Score Matching Analysis
by: Cui R, et al.
Published: (2019-12-01)

Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis
by: Wencheng Tan, et al.
Published: (2019-01-01)

Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation
by: Jia-Yan Ni, et al.
Published: (2019-01-01)

Feeding artery ablation before radiofrequency ablation for hepatocellular carcinoma may reduce critical recurrence
by: Ryo Shimizu, et al.
Published: (2021-04-01)